Today’s blog is from Ahmed Alharthi, who in undertaking a PhD at the University of Glasgow. Ahmed talks about the PhD journey.

I am a licenced clinical pharmacist by background, who works with Dr Terry Quinn, a consultant physician and geriatrician in the NHS and a reader in Geriatric Medicine department at the University of Glasgow. I am a second year PhD student, employed and sponsored by Umm Al Qura University in Saudi Arabia.

I completed my MSc in Clinical Pharmacology at the University of Glasgow, and then started to pursue my PhD in Cardiovascular Medicine. My PhD title is “Repurposing cardiovascular medicines for vascular dementia – a data driven clinical study”. My PhD work so far has focussed on dementia and associations with a group of medications called Anticholinergic drugs. I wish to understand the potential relationship between these commonly used medications and the incidence of dementia in older adults, because if there is a causal relationship this could suggest a potential modifiable risk factor.

In my work so far, I have conducted systemic reviews focused on evidence synthesis and had the opportunity to collaborate with the Cochrane Dementia Group, resulting in published paper. I am currently working on a dataset from a completed cohort the APPLE study. This offers me participant-level data that contain high-quality information on medications prescribed and consumed, with detailed information on changes in medication over time. This level of detail is often missing in studies that contain information on prescribed medications, but to truly understand the relationship between medications and dementia this granularity of medication data is required.

Given my professional background, I was eager for my PhD to include content related to clinical pharmacy practice. Among the ideas I have discussed with my supervisors are a real-world analysis of anticholinergic prescribing in Greater Glasgow and Clyde secondary care and a qualitative piece contrasting prescribers’ opinions on anticholinergic prescribing and the use of scales to identify anticholinergic risk.

I was motivated towards pursuing a PhD with a cognition and medications focus, as I was aware of the crucial role of clinical pharmacy to enhance medications use and possibly to improve cognitive impairment by adopting novel treatment approaches.

I am especially excited around the next step of my research, working with Dr Donald Lyall, my second supervisor. I will move from a relatively large dataset (APPLE Study) to a truly bigdata project, assessing for associations of cardiovascular medications and dementia in the UK Biobank, one of the largest biomedical databases in the world.

I am keen to engage with the Scottish dementia research community and look forward to meeting other researchers.

Read more SDRC Blogs

Project Update: Kelly Kelly at Celebrating Scottish Research Conference 2024

  Alzheimer Scotland Student Research Programme: update from 2023 recipient Kelly Kelly    In 2023, Kelly Kelly began her MRes project as part of the Alzheimer Scotland Student Research Programme. Kelly’s studentship is hosted by the Alzheimer Scotland Centre for...

Early Career Researchers: Martha Pollard

We hope you are enjoying our blog series which is celebrating our next generation of researchers, featuring those that were in the SDRC Annual Report 2019/20.  Our final blog is by Martha Pollard, from the Alzheimer Scotland Dementia Resource Centre. Read about...

Dementia Awareness Week 2023

Each year, Dementia Awareness Week (DAW) is held with the aim of raising awareness of dementia and helping improve the lives of people with dementia, their families, and carers. Find out more about Dementia Awareness Week on the Alzheimer Scotland website. In 2023,...

COVID Impact on ECRs: Mohammad Mainuddin Mollah

Today's blog is part a series of featuring Early Career Researchers who are sharing how COVID has impacted their research and career prospects.  Today's blog is by Mohammad Mainuddin Mollah, providing insight to supervisory support experiences of an international PhD...

COVID Impact on ECRs: Rose Vincent

Read today's COVID Impact blog from Rose Vincent, who has recently started a PhD at the University of Edinburgh. This part of a series of many blogs from students and ECRs on how COVID has affected their research and also featuring many practical advice for those...

Founding SDRC Executive Committee Member Debbie Tolson Retires

After a remarkable career dedicated to advancing dementia research and practice, Professor Debbie Tolson is stepping down from her role as an Executive Committee Member of the Scottish Dementia Research Consortium. A founding member of the SDRC since its inception in...

Guest Blog: Rachel Allen

Today's blog is from Rachel Allen, a PhD candidate form the Alzheimer Scotland Centre for Policy and Practice at the University of the West of Scotland. Rachel talks about the PhD journey and the process of research. My name is Rachel Allen, and I am in my second year...

Guest Blog: Young Dementia Network

Guest Blog: Young Dementia Network   The Young Dementia Network is an online influencing community working collaboratively to improve lives of people living with young onset dementia and their families now and create positive change for the future. Launched in...

Early Career Researchers: Emma Russell

Read our new blog below from Emma Russell, as part of the SDRC's series of blogs from PhD Students/ Early Career Researchers in dementia and brain health.  Follow us on Twitter to keep up to date with the series.  I am a doctoral candidate studying at the University...

Early Career Researchers: Ilaria Pina

Today's blog in SDRC's series from PhD Students and Early Career Researchers is by Ilaria Pina. You can read the full blog series so far here, and keep up to date with the rest of the series, as well updates of all SDRC activity by following us on Twitter.  Hi! I’m...